Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Study of DTaP-IPV-Hep B-PRP~T in Turkish Infants
NCT00619502Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2007
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hexaxim in diphtheria, Tetanus, pertussis, poliomyelitis, hepatitis B (HBV), sponsored by Sanofi. Started Dec 2007; status: completed.
02
Drugs
hexaxim
03
Conditions
diphtheriaTetanuspertussispoliomyelitishepatitis B (HBV)
Beyond the preview
Go deeper on NCT00619502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619502.